Back to results
UnknownN/A

Efficacy and Safety Evaluation of Tolvaptan in the Treatment of Patients With RHF Caused by PAH

NCT05569655

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

center of pulmonary vascular disease, Fuwai hospital

Beijing, China

View on ClinicalTrials.gov
Efficacy and Safety Evaluation of Tolvaptan in the Treatment of Patients With RHF Caused by PAH — TrialFind